SUMMER SAVON: Open Payments
NPI 1629376462 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 32 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $465 · 2025 $982
Food & beverage: $871Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $314 |
| ABBVIE INC. | 8 | $198 |
| E.R. Squibb & Sons, L.L.C. | 5 | $135 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Neurocrine BioSciences, Inc. | 3 | $88 |
| Alkermes, Inc. | 3 | $86 |
| Janssen Pharmaceuticals, Inc | 1 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: UZEDY, VRAYLAR, COBENFY, INGREZZA, REXULTI, VIVITROL, INVEGA SUSTENNA, ARISTADA.
Industry payments across CA — which companies pay providers there.
